Carmine Zoccali
From Wikipedia, the free encyclopedia
Carmine Zoccali | |
|---|---|
| Born | 27 January 1947 (age 79) |
| Citizenship | Italian |
| Alma mater | University of Rome, University of Pisa |
| Known for | Cardiovascular Risk in Chronic Kidney Disease (CKD), Risk factors for CKD progression, Endothelial dysfunction and hypertension in CKD and in End Stage Kidney Disease (ESKD), Epidemiology of kidney diseases |
| Scientific career | |
| Fields | Nephrology, dialysis, epidemiology, hypertension, cardiovascular risk |
| Institutions | CNR (National Research Council of Italy)-Clinical Physiology Institute (Clinical Epidemiology of Renal Diseases and Hypertension Unit), |
Carmine Zoccali (born January 1947) is an Italian nephrologist and a clinical investigator. He has contributed to research in several fields, most notably hypertension and cardiovascular complications in chronic kidney disease (CKD), CKD progression and clinical epidemiology of kidney diseases at large. He is known for his studies on cardiovascular risk in CKD and dialysis patients. He was among the earliest investigators that focused on the relevance of endothelial dysfunction[1] and inflammation[2] for the high risk of cardiovascular disease in these populations. In this research area, he was the first to link endogenous inhibitors of the nitric oxide system with death and cardiovascular disease.[3] and the first to document a relationship between sympathetic over-activity and these outcomes[4] Dr Zoccali is a practicing specialist in Nephrology, with a national qualification for the full professorship in Nephrology. He is also a specialist in hypertension, certified by the European Society of Hypertension (ESH).[5]
He received his education in medicine from the Sapienza University of Rome where he graduated in 1971. He then specialized in Nephrology at the University of Pisa. His nephrology mentor was Professor Quirino Maggiore, the investigator that in the sixties proposed a special low-protein diet (the Giovannetti-Maggiore diet)[6] for the control of uremic symptoms and invented cold-dialysis in the early eighties. Dr Zoccali was trained in clinical research in hypertension at the Medical Research Council (MRC) BP Unit in Glasgow (1981-1982) and in Epidemiology and Biostatistics at the Erasmus University Rotterdam where he attended several Erasmus Summer School courses in 1989–1993.